Laboratory investigations from admission up to discharge and then on follow-up
| Investigations | On admission to this hospital | On admission to another hospital | Second day | Third day | Fifth day | Seventh day | Follow-up 1 month after discharge | Reference range |
| Haemoglobin, g/L | 143 | 136 | 140 | 134 | 140 | 154 | 139 | 115–164 |
| White cell count, 109/L | 9.2 | 5.8 | 9.3 | 14.2 | 13.8 | 9.2 | 5.9 | 4–11 |
| Neutrophils, 109 /L | 7.7 | 3.9 | 1.9–7.5 | |||||
| Lymphocytes, 109 /L | 0.8 | 1.4 | 1–4 | |||||
| Platelets, 109 /L | 66 | 87 | 110 | 164 | 188 | 200 | 194 | 150–400 |
| Alanine aminotransferase, iU/L | 83 | 87 | 78 | 144 | 0–40 | |||
| Alkaline phosphatase, iU/L | 317 | 296 | 290 | 266 | 30–130 | |||
| Gamma glutamyl transferase, iU/L | 194 | 240 | 6–42 | |||||
| Total bilirubin, μmol/L | 11 | 12 | 10 | 8 | 0–21 | |||
| Albumin, g/L | 42 | 35 | 36 | 47 | 35–50 | |||
| Total protein, g/L | 73 | 74 | 60–80 | |||||
| Prothrombin time, seconds | 13 | 12 | 9–14 | |||||
| International normalised ratio | 1.0 | 1.0 | 1.0 | 0.8–1.2 | ||||
| activated partial thromboplastin time, seconds | 30 | 31 | 24–35 | |||||
| D-dimer assay, ng/mL | 6735 | 235 | Less than 500 | |||||
| Fibrinogen assay, g/L | 4.12 | 3.64 | 2–6 | |||||
| C reactive protein, mg/L | 19 | 25 | 2 | 0–10 | ||||
| Urea, mmol/L | 2.5 | 3.5 | 3.8 | 2.9 | 2.5–7.8 | |||
| Creatinine, μmol/L | 57 | 53 | 57 | 61 | 44–80 | |||
| estimated glomerular filtration rate, mL/min | >90 | >90 | ||||||
| Sodium, mmol/L | 137 | 135 | 139 | 141 | 133–146 | |||
| Potassium, mmol/L | 4.1 | 4.0 | 4.0 | 4.1 | 3.5–5.3 | |||
| Chloride, mmol/L | 104 | 95–108 | ||||||
| Bicarbonate, mmol/L | 27.2 | 22–29 | ||||||
| Glucose, mmol/L | 7.0 | 4.0–7.8 | ||||||
| Lactate, mmol/L | 1.4 | 1–1.5 | ||||||
| pH | 7.48 | 7.35–7.45 | ||||||
| Antiplatelet factor 4 antibodies | >3.0 OD | 2.87 OD | <0.4 negative 0.4–1.0 weakly positive >1.0 positive |
OD, optical density.